News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By David Zucchino, Los Angeles Times | 01.25.2012

Reporting from Raleigh, N.C.— Elaine Riddick was a confused and frightened 14-year-old. She was poor and black, the daughter of...

By Cornelia Dean, New York Times | 01.25.2012
Tiny substances called nanomaterials have moved into the marketplace over the last decade, in products as varied as cosmetics, clothing...
By Fiona MacDonald, Sydney Morning Herald | 01.25.2012

Not every fitness regime will have the same impact on all types of bodies, but just how personal does a...

By Ayesha Ahmad, BioNews | 01.23.2012

Myriad Genetics, a leading US molecular diagnostic company, has been granted exclusive rights to an analysis of the RAD51C gene...

By Ayesha Ahmad, BioNews | 01.23.2012

Myriad Genetics, a leading US molecular diagnostic company, has been granted exclusive rights to an analysis of the RAD51C gene...

By Harriet A. Washington, Slate | 01.22.2012

Sixty-five years ago in Nuremberg, Germany, American prosecutors confronted the Nazi physicians who had subjected Jews and others to a...

By Harriet A. Washington, Slate | 01.22.2012

Sixty-five years ago in Nuremberg, Germany, American prosecutors confronted the Nazi physicians who had subjected Jews and others to a...

By Michael Hiltzik, Los Angeles Times | 01.21.2012
What are the chances that the prestigious Institute of Medicine will get an objective and balanced view of California’s stem-cell...